Back to ATRA

Atara Biotherapeutics, Inc. 8-K

Accession 0001193125-22-252141

Filing information

CIK
0001604464
Report date
2022-09-26
Filing date
2022-09-27
Form
8-K
Primary document
d400712d8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.